Conversely, targeting of miR-98 by a miR-98 inhibitor promoted mitochondrial fusion, sensitizing cancer cells to cisplatin-induced apoptosis, with downregulation of Drp1 phosphorylation at S616. Here, DNM1L is linked to cancer.